Amgen Inc (NASDAQ:AMGN)
| 269.62 Delayed Data As of Nov 30 |  +3.04 / +1.14%Today’s Change | 211.71 Today|||52-Week Range 288.46 | +2.66% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Bradway Robert A Chairman, President & Chief Executive Officer |  Sale | 3/17/2023 | 13,971 | $234.57 | $3.3M | +17.34% |
Graham Jonathan P | Sale | 11/08/2023 | 10,000 | $272.81 | $2.7M | -1.32% |
Gordon Murdo J /rwj/ EVP-Global Commercial Operations | Sale | 8/10/2023 | 9,558 | $262.43 | $2.5M | +2.89% |
Gordon Murdo J /rwj/ EVP-Global Commercial Operations | Sale | 3/17/2023 | 3,978 | $234.57 | $933.1K | +17.34% |
Reese David M /amgen/ EVP-Research & Development | Sale | 3/17/2023 | 3,978 | $234.57 | $933.1K | +17.34% |
Santos Esteban EVP-Operations | Sale | 3/17/2023 | 3,881 | $234.57 | $910.4K | +17.34% |
Griffith Peter H Chief Financial Officer & Executive Vice President | Sale | 11/01/2023 | 3,502 | $255.70 | $895.5K | +3.37% |
Graham Jonathan P | Sale | 3/17/2023 | 3,785 | $234.57 | $887.8K | +17.34% |
Griffith Peter H Chief Financial Officer & Executive Vice President | Sale | 3/17/2023 | 3,403 | $234.57 | $798.2K | +17.34% |
Bradway Robert A Chairman, President & Chief Executive Officer | Sale | 5/03/2023 | 2,863 | $235.97 | $675.6K | +17.59% |
Page of 9